Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

416 trials

NCT07672860
Recruiting
Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors
Phase 2 · China · 1 site
Registry update: 15 Oct 2026
NCT07611825
Recruiting
Gut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma
Phase 2 · China · 1 site
Registry update: 3 Aug 2026
NCT07584499
Recruiting
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
Phase 1 · China · 1 site
Registry update: 13 May 2026
NCT07419841
Recruiting
A Phase 1 Study of the Safety and Tolerability of CTX-10726
Phase 1 · United States · 8 sites
Registry update: 23 Oct 2026
NCT07805122
Recruiting
Intensified Monitoring of PhArmacology of Cabozantinib as a Tool for Toxicity Management in Patients With Renal Cell Carcinoma
Not applicable · Italy · 1 site
Registry update: 4 Sept 2026
NCT07634380
Recruiting
Sitagliptin With Pembro in RCC and Melanoma
Phase 1 · United States · 1 site
Registry update: 30 Jul 2026
NCT06882486
Recruiting
Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic Therapy
Not applicable · France · 1 site
Registry update: 14 Oct 2026
2025-524160-38-00
Recruiting
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
Phase 3 · Belgium, Czechia, Germany, Denmark, Spain, Finland, France, Hungary, Netherlands, Poland · 24 sites
Registry update: 11 Nov 2026
NCT07571551
Recruiting
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma
Phase 2 · China · 1 site
Registry update: 11 May 2026
NCT07739121
Recruiting
Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
Not applicable · France · 5 sites
Registry update: 7 Oct 2026
NCT07188896
Recruiting
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
Phase 2 · United States · 5 sites
Registry update: 4 Sept 2026
NCT07557225
Recruiting
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Not applicable · China · 1 site
Registry update: 14 May 2026
NCT07405086
Recruiting
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
Phase 4 · United States · 1 site
Registry update: 13 Oct 2026
NCT07510334
Recruiting
VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Phase 2 · United States · 1 site
Registry update: 5 Jun 2026
NCT07753343
Recruiting
Identification and Description of Patients With High-risk Non Metastatic RCC
Not applicable · France · 1 site
Registry update: 7 Aug 2026
NCT07517198
Recruiting
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Phase 1 · United States · 3 sites
Registry update: 10 Jun 2026
NCT07489495
Recruiting
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
Phase 3 · Argentina, Australia, Brazil, Canada, Chile, Czechia, Germany, Denmark, Spain, France, United Kingdom, Greece, Israel, Italy, South Korea, Netherlands, Poland, Türkiye, United States · 114 sites
Registry update: 10 Nov 2026
NCT06783348
Recruiting
Radiopharmaceutical Treatment of Advanced Kidney Cancer
Phase 2 · Belgium, Spain, France · 11 sites
Registry update: 4 Jun 2026
NCT07402109
Recruiting
CBCT Guided Markerless SBRT for Renal Cell Cancer
Not applicable · Netherlands · 1 site
Registry update: 8 Apr 2026
NCT07293351
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Phase 1/2 · Argentina, Australia, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, Spain, Finland, France, United Kingdom, Ireland, Italy, Japan, South Korea, Mexico, Romania, United States · 96 sites
Registry update: 23 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.